Neural and Cognitive Consequences of COVID-19 Survival
This study investigates the long-term effects of COVID-19 on the brain and thinking abilities in people who have survived the infection. Researchers want to understand how COVID-19 may affect memory, concentration, and other cognitive functions, as well as examine any changes in the brain.
Key Objective: This trial aims to identify and better understand the neurological and cognitive problems that can persist after COVID-19 infection so that treatments can be developed.
Who to Consider: People who have recovered from COVID-19 but are experiencing ongoing cognitive difficulties, brain fog, memory problems, or other neurological symptoms should consider enrolling in this study.
Trial Parameters
Brief Summary
The novel coronavirus SARS-CoV-2 infection, COVID, continues to rage throughout the world with 115,000,000 confirmed cases and over 2,500,000 deaths (as of Mar 3, 2021). This translates to millions of people surviving COVID19 infection. While the lungs are ground zero, COVID tears through organ systems from brain to blood vessels. We are now beginning to see people recover but complain of ongoing problems, including lingering cognitive problems, depression, and anxiety. We have brought together 2 laboratories with complementary techniques including psychological testing and neuroimaging methods togethers with markers in the blood that may signal damage in the brain. A close look at these problems is timely and imperative if we are to understand the pathophysiology of 'COVID brain' and prepare for downstream problems.
Eligibility Criteria
Inclusion Criteria: * Our studies require some in-person visits to our research lab, located at 42nd Ave and Clement St in San Francisco. * Because this study includes an MRI, part of the screening process will be to ensure you don't have any metal in your body, you do not have head or neck tattoos, and you are comfortable inside the MRI scanner. * 18-70 years with a confirmed COVID infection at least 3 months ago. * Negative metal screen for MRI safety * Normal (or corrected to normal) vision Exclusion Criteria: * Past or present neurological problems (including seizures and head trauma resulting in neurological or cognitive symptoms) * Loss of consciousness (LOC) greater than 30 minutes or any LOC with neurologic symptoms * Major medical conditions (e.g., seizures disorders, treatment with anticonvulsant medication, endocrine disorders, significant cardiac pathology) * Substance dependence, within the past year, or failed urine toxicology on the day of neuroimaging sessions * Known c